Global Artificial Tears Market Size to Reach USD 3,916.83 Million By 2030
Category : Pharmaceuticals And Healthcare | Published Date : Jul 2024
Artificial Tears Market Scope & Overview :
Artificial tears are eye drops used to lubricate and moisten dry eyes. They contain synthetic tears and thickening agents to reduce tear evaporation and keep the solution on the eyes for longer. They are mainly used for dry eye syndrome, allergies, and infections.
Consegic Business Intelligence analyzes that the Global Artificial Tears Market size was valued at USD 2,626.46 Million in 2022 and is expected to register a CAGR of 5.2% to reach USD 3,916.83 Million by 2030.
This report comprises Artificial Tears Market Share, Size & Industry Analysis, By Type (Glycerin-Derived Tears, Cellulose-Derived Tears, Oil-based Emulsion Tears, Polyethylene Glycol-based Tears, and Others), By Form (Eye Drop, Ointment, Spray, and Others), By Application (Dry Eye Syndrome, Allergies and Infections, and Others), By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa), and Forecast, 2023-2030.
This report contains detailed information on Artificial Tears Market Trends, Opportunities, Value, Growth Rate, Segmentation, Geographical Coverage, Company Profile, In-depth Expert Analysis, Revenue Forecast, Competitive Landscape, Growth Factors, Restraint or Challenges, Environment & Regulatory Landscape, PESTLE Analysis, PORTER Analysis, Key Technology Landscape, Value Chain Analysis, and Cost Analysis.
As per the report analysis, the global artificial tears industry is seeing advancements in synthetic tear technology to address dry eye syndrome. The rising dry eye syndrome, in which tears aren't able to provide adequate lubrication to the eyes, is propelling the artificial tears market demand.
Segmental Analysis :
The Artificial Tears Market is segmented based on type, form, application, and region.
Based on type, the market is divided into Glycerin Derived Tears, Cellulose Derived Tears, Oil-based Emulsion Tears, Polyethylene Glycol-based Tears, and Others
- In 2022, glycerin-derived tears had the highest market share of 38.23% as they aid epithelial cell growth, reduce the damaging effects of high osmolarity on the eyes, and effectively treat eye allergies.
- Over the forecast period, Polyethylene glycol-based tears are the fastest-growing segment due to increasing demand for ocular surface protection and relief of inflammation.
Based on the form, the market is segregated into Eye Drop, Ointment, Spray, and Others.
- In 2022, the eye drop segment dominated the market attributed to the fact that eye drops effectively provide relief for dry eyes by lubricating the eyes and soothing irritation.
- During the forecast period, the ointment segment is expected to experience the fastest CAGR growth, driven by an increasing number of eye surgeries, allergy treatments, and other related factors.
Based on the application, the market is segregated into Dry Eye Syndrome, Allergies and Infections, and Others.
- In 2022, artificial tears for dry eye syndrome held the largest market share as artificial tears protect dry ocular tissue from damage, increase healing of epithelial tissues, and are optically clear, lubricating, and soothing.
- The allergies and infections segment is projected to witness the fastest CAGR growth throughout the forecast period due to a rise in eye-related issues including inflammations, allergic reactions to specific medications, and others.
By region, the market is segregated into regions including North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
- In 2022, North America accounted for 36.95% of the total market, valued at USD 970.48 million, and is expected to reach USD 1,453.53 million in 2030 due to increasing eye-related concerns in the region. The U.S. had the highest market share of 68.75% in 2022 among the region.
- Asia Pacific is expected to see substantial growth, with a 6.2% CAGR during 2023-2030, due to increasing demand for preservative-free tears to treat allergies, dry eye syndrome, and other conditions.
| Report Attributes | Report Details |
| By Type | Glycerin Derived Tears, Cellulose Derived Tears, Oil-based Emulsion Tears, Polyethylene Glycol-based Tears, and Others |
| By Form | Eye Drop, Ointment, Spray, and Others |
| By Application | Dry Eye Syndrome, Allergies and Infections, and Others |
| By Region | North America(U.S., Canada, Mexico) Europe(U.K., Germany, France, Spain, Italy, Russia, Benelux, Rest of Europe) APAC(China, South Korea, Japan, India, Australia, ASEAN, Rest of Asia-Pacific) Middle East & Africa(GCC, Turkey, South Africa, Rest of MEA) LATAM(Brazil, Argentina, Chile, Rest of LATAM) |
Top Key Players & Competitive Landscape :
The competitive landscape encompasses major innovators, aftermarket service providers, industry giants, and niche players, all of which are thoroughly examined by Consegic Business Intelligence in terms of their strengths, weaknesses, and value-addition potential. Additionally, this report includes detailed profiles of key players, market share analysis, mergers and acquisitions, resulting market fragmentation, and emerging partnership trends and dynamics.
List of prominent players in the Artificial Tears Industry :
- Allergen
- Alcon
- Johnson & Johnson
- Nicox S.A.
- OASIS Medical
- OCuSOFT Inc.
- Santen Pharmaceutical Co. Ltd.
- Similasan Corporation
- Sun Pharmaceutical Industries Ltd.
- URSAPHARM Arzneimittel GmbH
Recent Industry Developments :
- In January 2022, Alcon introduced Systane Complete Preservative-Free Lubricant Eye Drop to its European dry eye products portfolio, aiming to expand its presence in the European market.
- In July 2021, Bausch + Lomb launched Biotrue Hydration Boost Lubricant Eye Drops to broaden its product offering for artificial tears in the global market.
- In October 2019, Allergan plc unveiled three new ranges of artificial tears, including REFRESH RELIEVA for contacts, REFRESH RELIEVA, and REFRESH RELIEVA PF multidose, designed to minimize discomfort from eye dryness and protect from further irritation.